Premature stroke and cardiovascular risk in primary Sjögren's syndrome.
EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)
Raynaud disease
Sjögren syndrome
atherosclerosis
cardiovasclar disease
cardiovascular risk factors
stroke
vasculitis
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
09
2022
accepted:
28
11
2022
entrez:
2
1
2023
pubmed:
3
1
2023
medline:
3
1
2023
Statut:
epublish
Résumé
Primary Sjögren's syndrome (pSS) is associated with an increased prevalence of traditional risk factors and cardiovascular diseases (CVDs). The study aimed to identify specific risk factors for CVD in pSS patients. PSS patients with and without CVD were compared. All patients fulfilled the EULAR/ACR classification criteria. Patients with CVD presented at least one of the following manifestations: myocardial infarction, transient ischemic attacks, ischemic or hemorrhagic stroke, peripheral artery disease, coronary artery disease, and carotid plaques. Data were collected by a standardized protocol and review of medical records. 61/312 (19.6%) pSS patients presented with CVD. Traditional risk factors such as hypertension, hypercholesterinemia and diabetes ( Raynaud's phenomen as well as vasculitis and high ESSDAI have shown a significant association to CVD. PSS patients with cerebrovascular events were younger than expected. Knowledge about risk factors may help clinicians to identify pSS patients at risk for CVD. After diagnosis of pSS, patients should be screened for risk factors such as hypertension and receive appropriate therapy to prevent or at least reduce sequelae such as infarction. However, further investigations are necessary in order to achieve a reliable risk stratification for these patients.
Identifiants
pubmed: 36588566
doi: 10.3389/fcvm.2022.1048684
pmc: PMC9794609
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1048684Informations de copyright
Copyright © 2022 Zippel, Beider, Kramer, Konen, Seeliger, Skripuletz, Hirsch, Jablonka, Witte, Sonnenschein and Ernst.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nutrients. 2021 Jun 17;13(6):
pubmed: 34204342
Can J Cardiol. 2000 Apr;16(4):515-8
pubmed: 10787467
Ther Adv Musculoskelet Dis. 2016 Jun;8(3):86-101
pubmed: 27247635
Clin Exp Rheumatol. 2014 May-Jun;32(3):361-8
pubmed: 24565029
Eur J Rheumatol. 2022 Jan;9(1):20-25
pubmed: 35110133
J Immunol Res. 2014;2014:647507
pubmed: 24963499
Arthritis Care Res (Hoboken). 2020 Jan;72(1):131-139
pubmed: 30570824
Arthritis Rheumatol. 2017 Jan;69(1):35-45
pubmed: 27785888
Ann Rheum Dis. 2017 Jan;76(1):17-28
pubmed: 27697765
J Immunol Res. 2018 Apr 5;2018:8174340
pubmed: 29850640
Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87
pubmed: 22563590
Rheumatology (Oxford). 2020 Jun 1;59(6):1355-1363
pubmed: 31600392
J Rheumatol. 2021 Jun;48(6):859-866
pubmed: 32934134
Acta Reumatol Port. 2019 Jan-Mar;44(1):71-77
pubmed: 31249278
Dtsch Arztebl Int. 2016 Oct 21;113(42):704-711
pubmed: 27866565
Semin Intervent Radiol. 2014 Dec;31(4):378-88
pubmed: 25435665
Isr Med Assoc J. 2020 Jul;22(7):458-460
pubmed: 33236575
Lupus. 2010 Jul;19(8):941-8
pubmed: 20581017
BMJ. 2012 Jun 14;344:e3821
pubmed: 22700787
Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):91-9
pubmed: 24287197
Adv Clin Exp Med. 2018 Nov;27(11):1587-1592
pubmed: 29558039
J Clin Pathol. 1968 Sep;21(5):656-60
pubmed: 5697370
Clin Rheumatol. 2016 Mar;35(3):639-47
pubmed: 26370103
Ann Rheum Dis. 2015 Nov;74(11):1983-9
pubmed: 24938285
Microvasc Res. 2020 Nov;132:104040
pubmed: 32768463
Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):97-106
pubmed: 31464664
Arch Intern Med. 2001 Dec 10-24;161(22):2657-60
pubmed: 11732929
Am Fam Physician. 2020 Oct 1;102(7):427-433
pubmed: 32996756
Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):133-139
pubmed: 31464678
Clin Rheumatol. 2019 Feb;38(2):447-455
pubmed: 30178172
Front Immunol. 2019 Apr 17;10:817
pubmed: 31110500
Clin Exp Rheumatol. 1992 Jul-Aug;10(4):351-6
pubmed: 1395220
Lancet. 2012 Aug 25;380(9843):767-77
pubmed: 22575778
Front Immunol. 2019 Jul 11;10:1600
pubmed: 31354737
Sci Rep. 2018 Feb 2;8(1):2209
pubmed: 29396489
J Rheumatol. 1998 Dec;25(12):2385-8
pubmed: 9858434
J Intern Med. 2015 Aug;278(2):185-92
pubmed: 25582881
Autoimmun Rev. 2016 Jan;15(1):22-37
pubmed: 26455562
Arthritis Care Res (Hoboken). 2014 May;66(5):757-64
pubmed: 24877201
Ann Rheum Dis. 2011 Jun;70(6):968-72
pubmed: 21345815
J Intern Med. 2019 Oct;286(4):458-468
pubmed: 31127862
J Neurol. 2013 Oct;260(10):2659-61
pubmed: 23996128
Ann Rheum Dis. 2010 Jun;69(6):1103-9
pubmed: 19561361
Heart. 2019 Nov;105(21):1656-1660
pubmed: 31315936
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):656-60
pubmed: 23703483